Véronique Lecault
Founder presso ABCELLERA BIOLOGICS INC.
Patrimonio netto: 43 M $ in data 31/03/2024
Profilo
La dottoressa Vronique Lecault è vicepresidente di Lineage Biosciences, Inc. e direttore operativo e direttore di AbCellera Biologics, Inc. Fa parte del consiglio di amministrazione di Trianni, Inc., Channel Biologics Pty Ltd. e AbCellera Biologics, Inc. Si è laureata presso l'Università di Ottawa e ha conseguito un dottorato presso l'Università della British Columbia.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 14/01/2024 | 9 530 340 ( 3.26% ) | 43 M $ | 31/03/2024 |
Posizioni attive di Véronique Lecault
| Società | Posizione | Inizio |
|---|---|---|
| ABCELLERA BIOLOGICS INC. | Founder | 08/11/2012 |
Lineage Biosciences, Inc.
 Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2018 |
| AbCellera Australia Pty Ltd. | Director/Board Member | 01/09/2019 |
Trianni, Inc.
 Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | 01/11/2020 |
Formazione di Véronique Lecault
| University of British Columbia | Doctorate Degree |
| University of Ottawa | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Health Services |
| AbCellera Australia Pty Ltd. |
- Borsa valori
- Insiders
- Véronique Lecault
